← Top Holdings
PTGXPROTAGONIST THERAPEUTICS INC
CUSIP: 74366E102
3
Guru Owners
$3.1M
Total Value Held
189,313
Total Shares
| Investor | Fund | Shares | Value▼ | % of Portfolio | Rpt Price | Period |
|---|---|---|---|---|---|---|
| Polen Capital Management | 24337 | $2.6M | 0.02% | $105.40 | Q1 2026 | |
| Bridgewater Associates | 5276 | $556K | 0.00% | $105.40 | Q1 2026 | |
| Duquesne Family Office | 159700 | $17K | 0.50% | $0.11 | Q1 2026 |
📊 Fundamentals
Market Cap$9.1B
Forward P/E-222.6x
EPS (TTM)$-1.80
Revenue (TTM)$74.1M
Profit Margin-154.88%
Beta1.79
52-Week Range
$49.38
$141.08
Current: $140.85
Data from Yahoo Finance · refreshed every 4 hours
📊 Holdings Over Time
How superinvestor ownership has changed across quarters
Quarter-by-Quarter Activity
Q1 '263 owners · $3.1M
Q4 '252 owners · $15.7M
Q3 '252 owners · $12.0M
Q2 '251 owners · $884K
No changes
💰 DCF Calculator
DCF model · 10-yr forecastEstimates depend entirely on your assumptions. Adjust the inputs below to explore scenarios.
⚠️ This company currently has negative free cash flow. The valuation assumes it will improve.
📊 Adjust the assumptions below to calculate an estimated fair value
Projection Period
Revenue Growth Rate
0%analyst est. -68.1%
0%100%
Growth Decay Rate
15%
0% (no decay)50% (fast decay)
Terminal Growth Rate
3.0%
0%5%
FCF Margin
5.0%current: -104.9%
1%50%
Discount Rate (WACC)
8.0%typical: 8% large caps · 10% growth
5%20%
Model: 10-year DCF · 3.0% terminal growth · Based on Yahoo Finance data